Related Experiment Videos
Enlarging solitary cysticercus granulomas
1Department of Neurological Sciences, Christian Medical College and Hospital, Vellore, India.
Journal of Neurosurgery
|May 1, 1994
Summary
Enlarging cysticercus granulomas, though rare, can mimic other conditions. Early recognition and appropriate management, including biopsy or albendazole therapy, are crucial for epilepsy patients with these lesions.
Area of Science:
- Neurology
- Infectious Diseases
- Radiology
Background:
- Solitary cysticercus granulomas typically measure <20 mm and do not enlarge.
- Epilepsy can be caused by various brain lesions, including cysticercus granulomas.
- Distinguishing cysticercus granulomas from other pathologies like tuberculomas is critical for treatment.
Purpose of the Study:
- To investigate the characteristics and management of enlarging solitary cysticercus granulomas.
- To differentiate enlarging cysticercus granulomas from stable lesions.
- To provide guidance on the diagnostic and therapeutic approach for these specific lesions.
Main Methods:
- Prospective follow-up study of 93 epilepsy patients with small, enhancing solitary lesions (<20 mm) on CT.
- Defined enlarging lesions based on size increase (>50% or >20 mm) on follow-up CT.
- Categorized patients into Group 1 (enlarged but <20 mm) and Group 2 (enlarged to >20 mm).
Main Results:
- 91 of 93 patients had solitary cysticercus granuloma.
- Seven patients (7.7%) presented with enlarging cysticercus granuloma.
- Group 1: 3 patients; Group 2: 4 patients.
Conclusions:
- Enlarging solitary cysticercus granuloma is a distinct entity that requires careful consideration.
- Excision biopsy is recommended for Group 2 lesions to rule out other pathologies.
- Albendazole therapy with early CT re-evaluation is a potential option for Group 1 and selected Group 2 lesions.